Medichoice Pvp Prep Solution
NDC Package 39892-0841-2
Package Information
Medichoice Pvp Prep Solution (povidone-iodine) solution is clean the affected areafor preparation of the skin prior to surgery, apply product to the operative sitefor use as a first aid antiseptic, apply a small amount of product to the area 1-3 times daily. This formulation utilizes a solution delivery system. Marketed by O&m Halyard, Inc., this product is identified by NDC 39892-0841 and is authorized under FDA application 505G(a)(3).
Identification & Billing
- RxCUI: 312564 - povidone-iodine 10 % Topical Solution
- RxCUI: 312564 - povidone-iodine 100 MG/ML Topical Solution
- RxCUI: 312564 - povidone-iodine 10 % (titratable iodine 1 % ) Topical Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 39892 - O&m Halyard, Inc.
- 39892-0841 - Medichoice Pvp Prep Solution
- 39892-0841-2 - 48 BOTTLE in 1 CASE / 118 mL in 1 BOTTLE
- 39892-0841 - Medichoice Pvp Prep Solution
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (39892-0841). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 39892-0841-2 identifies a specific commercial package of 48 bottle in 1 case / 118 ml in 1 bottle of Medichoice Pvp Prep Solution, a human over the counter drug labeled by O&m Halyard, Inc.. This solution is formulated for topical use and contains povidone-iodine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by O&m Halyard, Inc. on January 25, 2024. The current certification is valid through December 31, 2026.
How is this O&m Halyard, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 39892084102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.